Andrew Moon, MD, MPH, a fellow in the division of gastroenterology and hepatology, is lead author of a study finding one in five patients with NAFLD have prior prescription opioid use. Sidney Barritt, MD, MSCR, associate professor, is a co-author.
Target RWE, an innovative health evidence solutions company generating real-world evidence (RWE) and delivering regulatory-grade data, announced the latest data from its nonalcoholic steatohepatitis (NASH) study, published via Advanced Release (accepted, unedited manuscript) in聽
Learn more from the .